Lower FEV 1 in non-COPD, nonasthmatic subjects: Association with smoking, annual decline in FEV 1, total IgE levels, and TSLP genotypes

International Journal of COPD

Volumn 6, Issue 1, 2011, Pages 181-189

  Masuko, Hironori ^a   Sakamoto, Tohru ^a   Kaneko, Yoshiko ^a   Iijima, Hiroaki ^b   Naito, Takashi ^b   Noguchi, Emiko ^a   Hirota, Tomomitsu ^c   Tamari, Mayumi ^c   Hizawa, Nobuyuki ^a  

^a UNIVERSITY OF TSUKUBA   (Japan)

^b Tsukuba Medical Center   (Japan)

^c INST OF PHYS AND CHEMICAL RESEARCH   (Japan)

Author keywords

Airflow obstruction; Asthma; Chronic obstructive pulmonary disease; Pulmonary function test; Thymic stromal lymphopoietin

Indexed keywords

IMMUNOGLOBULIN E; THYMIC STROMAL LYMPHOPOIETIN; CYTOKINE;

ADULT; AGED; ARTICLE; CROSS-SECTIONAL STUDY; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; JAPANESE; MALE; MUTATOR GENE; NORMAL HUMAN; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT; TSLP GENE; ASTHMA; BLOOD; CHI SQUARE DISTRIBUTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; GENETICS; GENOTYPE; IMMUNOLOGY; JAPAN; LUNG; MIDDLE AGED; PATHOPHYSIOLOGY; PHENOTYPE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SMOKING; STATISTICAL MODEL; TIME; VITAL CAPACITY;

ADULT; AGED; ASTHMA; CHI-SQUARE DISTRIBUTION; CROSS-SECTIONAL STUDIES; CYTOKINES; FORCED EXPIRATORY VOLUME; GENOTYPE; HUMANS; IMMUNOGLOBULIN E; JAPAN; LINEAR MODELS; LUNG; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING; TIME FACTORS; VITAL CAPACITY; YOUNG ADULT;

EID: 79960941227     PISSN: 11769106     EISSN: 11782005     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Mannino DM, Buist AS, Petty TL, Enright PL, Redd SC. Lung function and mortality in the United States: data from the First National Health and Nutrition Examination Survey follow up study. Thorax. 2003; 58(5):388-393.
2. The Global Initiative for Chronic Obstructive Lung Disease: Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease (updated 2009). http://www.goldcopd.com
3. Köhler D, Fischer J, Raschke F, Schönhofer B. Usefulness of GOLD classifcation of COPD severity. Thorax. 2003;58(9):825.
4. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax. 2010;65(1):14-20.
5. De Marco R, Accordini S, Marcon A, et al. Risk factors for chronic obstructive pulmonary disease in a European cohort of young adults. Am J Respir Crit Care Med. [Epub 2010 Oct 8].
6. Saetta M, Turato G, Maestrelli P, Mapp CE, Fabbri LM. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163(6):1304-1309.
7. Opitz B, van Laak V, Eitel J, Suttorp N. Innate immune recognition in infectious and noninfectious diseases of the lung. Am J Respir Crit Care Med. 2010;181(12):1294-1309.
8. Kim EY, Battaile JT, Patel AC, et al. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med. 2008;14(6):633-640.
9. Sadeghnejad A, Ohar JA, Zheng SL, et al. Adam33 polymorphisms are associated with COPD and lung function in long term tobacco smokers. Respir Res. 2009;10:21.
10. Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med. 2009;361(27): 2599-2608.
11. Allakhverdi Z, Comeau MR, Jessup HK, et al. Thymic stromal lymphopoietin is released by human epithelial cells in response to microbes, trauma, or infammation and potently activates mast cells. J Exp Med. 2007;204(2):253-258.
12. Nakamura Y, Miyata M, Ohba T, et al. Cigarette smoke extract induces thymic stromal lymphopoietin expression, leading to T(H)2-type immune responses and airway infammation. J Allergy Clin Immunol. 2008;122(6):1208-1214.
13. Ziegler SF, Artis D. Sensing the outside world: TSLP regulates barrier immunity. Nat Immunol. 2010;11(4):289-293.
14. Ying S, O'Connor B, Ratoff J, et al. Thymic stromal lymphopoietin expression is increased in asthmatic airways and correlates with expression of Th2-attracting chemokines and disease severity. J Immunol. 2005;174(12):8183-8190.
15. Ying S, O'Connor B, Ratoff J, et al. Expression and cellular provenance of thymic stromal lymphopoietin and chemokines in patients with severe asthma and chronic obstructive pulmonary disease. J Immunol. 2008;181(4):2790-2798.
16. Harada M, Hirota T, Jodo AI, et al. TSLP promoter polymorphisms are associated with susceptibility to bronchial asthma. Am J Respir Cell Mol Biol. [Epub 2010 Jul 23].
17. Weiss ST. Lung function and airway diseases. Nat Genet. 2010;42(1): 14-16.
18. The Committee of Pulmonary Physiology, Japanese Respiratory Society: Guideline of respiratory function tests. Spirometry, flow-volume curve, diffusion capacity of the lung. Nihon Kokyuki Gakkai Zasshi. 2004;Suppl:1-56 [in Japanese].
19. Harada M, Hirota T, Jodo AI, et al. Functional analysis of the thymic stromal lymphopoietin variants in human bronchial epithelial cells. Am J Respir Cell Mol Biol. 2009;40(3):368-374.
20. Rijcken B, Weiss ST. Longitudinal analyses of airway responsiveness and pulmonary function decline. Am J Respir Crit Care Med. 1996;154:S246-S249.
21. Vaz Fragoso CA, Concato J, McAvay G, et al. The ratio of FEV1 to FVC as a basis for establishing chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2010;181(5):446-451.
22. The Committee of Pulmonary Physiology, Japanese Respiratory Society: The normal ranges of spirogram and arterial blood gas analysis in never-smoking Japanese. Nihon Kokyuki Gakkai Zasshi. 2001;39(5):S1-S17. [in Japanese].
23. Terwillinger JD, Ott J. Handbook of Human Genetic Linkage. Baltimore, MD: Johns Hopkins University Press; 1994.
24. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70(2):425-434.
25. Hunninghake GM, Soto-Quirós ME, Avila L, et al. TSLP polymorphisms are associated with asthma in a sex-specifc fashion. Allergy. 2010;65(12):1566-1575.
26. Hunninghake GM, Lasky-Su J, Soto-Quirós ME, et al. Sex-stratifed linkage analysis identifes a female-specifc locus for IgE to cockroach in Costa Ricans. Am J Respir Crit Care Med. 2008;177(8): 830-836.
27. Kohansal R, Martinez-Camblor P, Agustí A, Buist AS, Mannino DM, Soriano JB. The natural history of chronic airflow obstruction revisited: An analysis of the Framingham offspring cohort. Am J Respir Crit Care Med. 2009;180(1):3-10.
28. Kalhan R, Arynchyn A, Colangelo LA, Dransfeld MT, Gerald LB, Smith LJ. Lung function in young adults predicts airflow obstruction 20 years later. Am J Med. 2010;123(5):468.e1-e7.
29. O'Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse WW. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179(1):19-24.
30. Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in Never-Smokers: Results from the population-based BOLD Study. Chest. [Epub 2010 Sep 30].
31. Smelter D F, Sathish V, Thompson MA, Pabelick CM, Vassallo R, Prakash YS. Thymic stromal lymphopoietin in cigarette smoke-exposed human airway smooth muscle. J Immunol. 2010;185(5): 3035-3040.
32. Repapi E, Sayers I, Wain LV, et al. Genome-wide association study identifes fve loci associated with lung function. Nat Genet. 2010;42(1):36-44.
33. Hancock DB, Eijgelsheim M, Wilk JB, et al. Meta-analyses of genome-wide association studies identify multiple loci associated with pulmonary function. Nat Genet. 2010;42(1):45-52.
34. Probst-Hensch NM, Curjuric I, Pierre-Olivier B, et al. Longitudinal change of prebronchodilator spirometric obstruction and health outcomes: results from the SAPALDIA cohort. Thorax. 2010;65(2):150-156.